Thermo Fisher Scientific Inc., US8835561023

Thermo Fisher stock: Guggenheim sets USD 740.00 target for Thermo Fisher stock

Published on 10/19/2026 at 15:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due October 21, 2026. Thermo Fisher stock costs EUR 615.10 on October 19, 2026, up 0.11 percent versus the Xetra close.

Analyst target and trading position

Guggenheim initiated coverage with a USD 740.00 target on October 15, 2026.
Thermo Fisher will release third-quarter results on October 21, 2026, before the U.S. market opens.
Thermo Fisher stock traded at EUR 615.10 at 2:59 p.m. CEST on October 19, 2026, up 0.11 percent versus the Xetra close of October 16, 2026 at EUR 614.40.
Thermo Fisher had a USD 255.1 billion market capitalization and a 37.12 price-to-earnings ratio as of October 16, 2026.

Schwarzweißfoto eines Technikers an einem großen Bioreaktortank in einer Fertigungshalle — Schwarzweiße Reportage-Aufnahme für Thermo Fisher Sci. US8835561023 dokumentiert Techniker an industrieller Bioreaktor-Anlage im Werk, Illustration mit AI erstellt.

Thermo Fisher Scientific Inc. (ISIN US8835561023) drew a USD 740.00 price target from Guggenheim on October 15, 2026, putting the target 7.25 percent above the USD 690.00 home-market price. Markets Insider reported that Guggenheim initiated coverage with a Buy rating and the USD 740.00 target. Thermo Fisher Scientific stock was trading at EUR 615.10 at Lang & Schwarz on October 19, 2026 at 2:59 p.m. CEST, up 0.11 percent versus the Xetra close.

Results date is October 21, 2026

The next scheduled report is the key near-term date. Thermo Fisher Scientific said it will release third-quarter 2026 results before the U.S. market opens on October 21, 2026, followed by a conference call at 7:00 a.m. ET. The event gives the target a clear test: management will discuss both financial performance and future expectations.

Stock position on October 19, 2026

The euro quote stood 0.11 percent above the Xetra close of EUR 614.40 from October 16, 2026. The Lang & Schwarz bid was EUR 613.00 and the ask was EUR 617.20. The U.S. home-market price was last at USD 690.00 on October 16, 2026 at 4:00 p.m. EDT. Thermo Fisher's 52-week range was USD 435.27 to USD 704.00, leaving the U.S. price 1.99 percent below the high.

Valuation and market scale

Thermo Fisher carried a USD 255.1 billion market capitalization and a 37.12 price-to-earnings ratio as of October 16, 2026. Average trading volume was 2,144,939 shares, compared with 2,097,173 shares in the latest quoted session. The company operates in healthcare and medical diagnostics and research, with brands including Thermo Scientific, Applied Biosystems, Fisher Scientific and PPD.

Comparison with peers

Thermo Fisher Scientific Inc.: plus 0.11 percent, P/E 37.12, market capitalization USD 255.1 billion.

Danaher (NYSE, USD): minus 1.06 percent, P/E 40.68, market capitalization USD 161.0 billion.

Agilent Technologies (NYSE, USD): minus 1.47 percent, P/E 34.05, market capitalization USD 48.8 billion.

Price and market placement

Thermo Fisher's euro price remained below its recent high in the home market, while the U.S. valuation stood above both named peers' market multiples. The upcoming October 21, 2026 results date is the next scheduled point for a fresh operating update. The stock was trading at EUR 615.10 at Lang & Schwarz on October 19, 2026 at 2:59 p.m. CEST, up 0.11 percent versus the Xetra close of October 16, 2026 at EUR 614.40. The further course of trading is shown by the continuously updated real-time quote of Thermo Fisher Scientific stock.